IrmaMSainzMD

Pathology • Nacogdoches, TX

Anatomic Pathology, Clinical Pathology

Patholoy and Laboratory Medical Director

Join to view full profile

Dr. Sainz is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Sainz's full profile

Already have an account?

Office
1204 N Mound St
Nacogdoches, TX 75961
Phone+1 936-569-4615

Education & Training

Temple University HospitalResidency, Pathology-Anatomic and Clinical, 1992 - 1998
Universidad Autonoma de GuadalajaraClass of 1985

Certifications & Licensure

CA State Medical License 2006 - 2025
TX State Medical License 2010 - 2025
PA State Medical License 1993 - 2004

Publications & Presentations

PubMed

152 citations
Napsin A, a new marker for lung adenocarcinoma, is complementary and more sensitive and specific than thyroid transcription factor 1 in the differential diagnosis of p...
Bradley M. Turner, Philip T. Cagle, Irma M. Sainz, Junya Fukuoka, Steven S. Shen
Archives of Pathology & Laboratory Medicine. 2012-01-30
34 citations
Association of the Plasminogen Activator Inhibitor-1 Gene 4G/5G Polymorphism With ST Elevation Acute Myocardial Infarction in Young Patients
Irma Isordia-Salas, Alfredo Leaños-Miranda, Irma M. Sainz, Elba Reyes-Maldonado, Gabriela Borrayo-Sánchez
Revista Espanola De Cardiologia. 2009-04-01
20 citations
The inhibitory effect of HKa in endothelial cell tube formation is mediated by disrupting the uPA-uPAR complex and inhibiting its signaling and internalization.
Yuchuan Liu, Dian J. Cao, Irma M. Sainz, Yan Lin Guo, Robert W. Colman
American Journal of Physiology. Cell Physiology. 2008-07-01